This study underscores the critical role of the WISP1/MIF axis in promoting the malignant properties of MCF7 cells, a widely used model for non-invasive estrogen receptor-positive (ER+) breast cancer, and demonstrates how this signaling axis may complicate therapeutic strategies aimed at controlling metastasis and resistance. This evidence concerns the gene MIF and breast carcinoma.